CYBB and chronic granulomatous disease: However, loss-of-function variants in NOX2 complex components that decrease or abrogate superoxide generation induce hyperinflammation in chronic granulomatous disease (CGD) patients with 40–50% of patients developing CGD-IBD over time [39,40].